Issued Patents All Time
Showing 1–25 of 41 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12365659 | Non-polyamine based polyamine transport inhibitors and their use in the treatment of human cancers | Holly Moots, Patrick Maloney, Paul Hershberger, Satyamaheshwar Peddibhotla | 2025-07-22 |
| 12202807 | Methods for the synthesis of activated ethylfumarates and their use as intermediates | Kelly Sullivan Kraft, John J. Freeman, Paul Serwinski, Vincent Pavia, Navneet Kaur | 2025-01-21 |
| 12049453 | Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino ester | John J. Freeman, William Elliot Bay, Kelly Sullivan Kraft | 2024-07-30 |
| 11905268 | Anthranilic acid derivatives and their use in the treatment of human cancers | Holly Moots, Patrick Maloney, Paul Hershberger, Satyamaheshwar Peddibhotla | 2024-02-20 |
| 11820726 | Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria | Jean-Michel Brunel | 2023-11-21 |
| 11752113 | Polyamine transport inhibitors as antivirals | John Connor | 2023-09-12 |
| 11529322 | Spermine pro-drugs | Mukund Pandurang Tantak, Houssine Ikhlef | 2022-12-20 |
| 11479535 | Methods for the synthesis of activated ethylfumarates and their use as intermediates | Kelly Sullivan Kraft, John J. Freeman, Paul Serwinski, Vincent Pavia, Navneet Kaur | 2022-10-25 |
| 11345668 | Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic α-N-protected amino ester | John J. Freeman, William Elliot Bay, Kelly Sullivan Kraft | 2022-05-31 |
| 10870628 | Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic α-N-protected amino ester | John J. Freeman, William Elliot Bay, Kelly Sullivan Kraft | 2020-12-22 |
| 10858325 | Methods for the synthesis of activated ethylfumarates and their use as intermediates | Kelly Sullivan Kraft, John J. Freeman, Paul Serwinski, Vincent Pavia, Navneet Kaur | 2020-12-08 |
| 10710957 | Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria | Jean-Michel Brunel | 2020-07-14 |
| 10577331 | Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino ester intermediate | John J. Freeman, William Elliot Bay, Kelly Sullivan Kraft | 2020-03-03 |
| RE47750 | Anti-metastatic agents predicated upon polyamine macrocylic conjugates | Aaron Muth | 2019-12-03 |
| 10071969 | Methods for the synthesis of activated ethylfumarates and their use as intermediates | Kelly Sullivan Kraft, John J. Freeman, Paul Serwinski, Vincent Pavia, Navneet Kaur | 2018-09-11 |
| 9944609 | Formation of N-protected bis-3,6-(4-aminobutyl)-2, 5-diketopiperazine through a cyclic alpha-N-protected amino ester | John J. Freeman, William Elliot Bay, Kelly Sullivan Kraft | 2018-04-17 |
| 9926260 | Polyamine transport selective therapeutic agents with enhanced stability | Aaron Muth | 2018-03-27 |
| 9730902 | Polyamine transport inhibitors as novel therapeutics | Jennifer J. Archer | 2017-08-15 |
| 9629822 | Flavonoid based antiviral targets | Nuska Tschammer | 2017-04-25 |
| 9598351 | Polyamine transporter selective compounds as anti-cancer agents | — | 2017-03-21 |
| 9346741 | Polyamine transport selective therapeutic agents with enhanced stability | Aaron Muth | 2016-05-24 |
| 9285320 | Fluorescent cytotoxic compounds specific for the cellular polyamine transport system | — | 2016-03-15 |
| 9266815 | Anti-metastatic agents predicated upon polyamine macrocyclic conjugates | Aaron Muth | 2016-02-23 |
| 9212131 | Polyamine transport inhibitors as novel therapeutics | Jennifer J. Archer | 2015-12-15 |
| 9193691 | Methods for the synthesis of activated ethylfumarates and their use as intermediates | Kelly Sullivan Kraft, John J. Freeman, Paul Serwinski, Vinnie Pavia, Navneet Kaur | 2015-11-24 |